Ipsen Biopharmaceuticals Revenue and Competitors

Basking Ridge, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ipsen Biopharmaceuticals's estimated annual revenue is currently $1.4B per year.(i)
  • Ipsen Biopharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Ipsen Biopharmaceuticals has 7137 Employees.(i)
  • Ipsen Biopharmaceuticals grew their employee count by 3% last year.

Ipsen Biopharmaceuticals's People

NameTitleEmail/Phone
1
VPReveal Email/Phone
2
Bilingual Executive Assistant to the VP Global Medical AffairsReveal Email/Phone
3
Associate VP and Head, Due Diligence and IntegrationReveal Email/Phone
4
VPReveal Email/Phone
5
Chief Information Technology Architect, IT Strategy and TransformationReveal Email/Phone
6
Chief AccountantReveal Email/Phone
7
Chief Staff to the Chief Medical Officer and Head Global Medical Affairs (CMO/GMA)Reveal Email/Phone
8
Global Drug Product Development, VP and R&D Site Managing DirectorReveal Email/Phone
9
Executive Assistant to VP Treasury, Financing & Credit Management and to VP TaxReveal Email/Phone
10
VPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Ipsen Biopharmaceuticals?

Ipsen is a global specialty driven pharmaceutical company with a significant presence in primary care. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in over 30 countries worldwide. The Group has more than 4,600 employees all over the world.

keywords:N/A

N/A

Total Funding

7137

Number of Employees

$1.4B

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ipsen Biopharmaceuticals News

2022-04-17 - Global Cushing's Syndrome and Acromegaly Treatment ...

Corcept Therapeutics; HRA Pharma; Ipsen Biopharmaceuticals. The following geographical regions are included by the market: The scope of the...

2021-08-02 - Ipsen con­tin­ues its shop­ping spree with a $1B-plus deal for Ex­i­cure's next-gen oligonu­cleotides

Ipsen has been on a deal-mak­ing spree the last few weeks, shelling out more than a bil­lion dol­lars in two sep­a­rate deals to work on a mid-stage lev­odopa-in­duced dysk­i­ne­sia (LID) can­di­date and a pre­clin­i­cal BAX in­hibitor in sev­er­al can­cers. But on Mon­day, the com­pa­ny inked i ...

2021-06-17 - IPSEN S.A. Ipsen : launches Perspectives Matter around World Kidney Cance...

We need to talk about how we're feeling is the theme of World Kidney Cancer Day (WKCD) on 17 June 2021. To support this theme, Ipsen is launching Perspectives Matter; a social media campaign that brings to life the experiences and perspectives of people who have direct experience of kidney cance ...

2021-06-17 - IPSEN Ipsen : launches Perspectives Matter around World Kidney Cance...

We need to talk about how we're feeling is the theme of World Kidney Cancer Day (WKCD) on 17 June 2021. To support this theme, Ipsen is launching Perspectives Matter; a social media campaign that brings to life the experiences and perspectives of people who have direct experience of kidney cance ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1710.5M8426N/AN/A
#2
$3591.9M17694-1%N/A
#3
$134240M987544%$30.1B
#4
$15640M246141N/AN/A